nature.com

The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy - Nature Genetics

  • ️Salvayre, Robert
  • ️Sun Dec 24 2006
  • Brief Communication
  • Published: 24 December 2006

Nature Genetics volume 39, pages 28–30 (2007)Cite this article

Abstract

Neutral lipid storage disease comprises a heterogeneous group of autosomal recessive disorders characterized by systemic accumulation of triglycerides in cytoplasmic droplets. Here we report a neutral lipid storage disease subgroup characterized by mild myopathy, absence of ichthyosis and mutations in both alleles of adipose triglyceride lipase (PNPLA2, also known as ATGL). Three of these mutations are predicted to lead to a truncated ATGL protein with an intact patatin domain containing the active site, but with defects in the hydrophobic domain. The block in triglyceride degradation was mimicked by short interfering RNA directed against ATGL. NLSDM is distinct from Chanarin-Dorfman syndrome, which is characterized by neutral lipid storage disease with ichthyosis, mild myopathy and hepatomegaly due to mutations in ABHD5 (also known as CGI-58).

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Jordans, G.H. Acta Med. Scand. 145, 419–423 (1953).

    Article  CAS  Google Scholar 

  2. Dorfman, M.L. et al. Arch. Dermatol. 110, 261–266 (1974).

    Article  CAS  Google Scholar 

  3. Chanarin, I. et al. Br. Med. J. 1, 553–555 (1975).

    Article  CAS  Google Scholar 

  4. Lefèvre, C. et al. Am. J. Hum. Genet. 69, 1002–1012 (2001).

    Article  Google Scholar 

  5. Radom, J. et al. Eur. J. Biochem. 164, 703–708 (1987).

    Article  CAS  Google Scholar 

  6. Lass, A. et al. Cell Metab. 3, 309–319 (2006).

    Article  CAS  Google Scholar 

  7. Zimmermann, R. et al. Science 306, 1383–1386 (2004).

    Article  CAS  Google Scholar 

  8. Jenkins, C.M. et al. J. Biol. Chem. 279, 48968–48975 (2004).

    Article  CAS  Google Scholar 

  9. Villena, J.A. et al. J. Biol. Chem. 279, 47066–47075 (2004).

    Article  CAS  Google Scholar 

  10. Smirnova, E. et al. EMBO Rep. 7, 106–113 (2006).

    Article  CAS  Google Scholar 

  11. Zechner, R. et al. Curr. Opin. Lipidol. 16, 333–340 (2005).

    Article  CAS  Google Scholar 

  12. Grönke, S. et al. Cell Metab. 1, 323–330 (2005).

    Article  Google Scholar 

  13. Kurat, C.F. et al. J. Biol. Chem. 281, 491–500 (2006).

    Article  CAS  Google Scholar 

  14. Lake, A.C. et al. J. Lipid Res. 46, 2477–2487 (2005).

    Article  CAS  Google Scholar 

  15. Haemmerle, G. et al. Science 312, 734–737 (2006).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We wish to thank the patients and family members for their participation in this study. We are grateful to S. Cure for help in writing this manuscript and to J.C. Thiers for microscopy assistance. This study was supported by the Centre National de Génotypage (CNG), the Association Française contre les Myopathies (AFM), INSERM and University Paul Sabatier Toulouse-3.

Author information

Authors and Affiliations

  1. Centre National de Génotypage, Evry, 91057, Cedex, France

    Judith Fischer, Caroline Lefèvre & Mark Lathrop

  2. Department of Pediatrics, Radboud University Nijmegen Medical Centre, HB Nijmegen, NL-6500, The Netherlands

    Eva Morava

  3. Department of Internal Medicine, Centre Hospitalier Universitaire (CHU) de Nantes, Nantes, 1, 44093, France

    Jean-Marie Mussini

  4. Centre de Réference Pathologie Neuromusculaire, Institut de Myologie, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, 75651, Cedex 13, France

    Pascal Laforêt

  5. Institut National de la Santé et de la Recherche Médicale (INSERM) U-466, University Paul Sabatier, Institute Fédératif de Recherche (IFR)-31, CHU Rangueil, Toulouse, 31432, Cedex 04, France

    Anne Negre-Salvayre & Robert Salvayre

Authors

  1. Judith Fischer

    You can also search for this author in PubMed Google Scholar

  2. Caroline Lefèvre

    You can also search for this author in PubMed Google Scholar

  3. Eva Morava

    You can also search for this author in PubMed Google Scholar

  4. Jean-Marie Mussini

    You can also search for this author in PubMed Google Scholar

  5. Pascal Laforêt

    You can also search for this author in PubMed Google Scholar

  6. Anne Negre-Salvayre

    You can also search for this author in PubMed Google Scholar

  7. Mark Lathrop

    You can also search for this author in PubMed Google Scholar

  8. Robert Salvayre

    You can also search for this author in PubMed Google Scholar

Contributions

E.M., J.-M.M. and P.L. provided patient material and clinical information. J.F. and C.L. designed and performed the genetic part of the study, R.S. and A.N.-S. designed and performed the biochemical part of the study, M.L. provided infrastructure and J.F. and R.S. contributed to the writing of this paper.

Corresponding authors

Correspondence to Judith Fischer or Robert Salvayre.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

About this article

Cite this article

Fischer, J., Lefèvre, C., Morava, E. et al. The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. Nat Genet 39, 28–30 (2007). https://doi.org/10.1038/ng1951

Download citation

  • Received: 30 June 2006

  • Accepted: 27 November 2006

  • Published: 24 December 2006

  • Issue Date: 01 January 2007

  • DOI: https://doi.org/10.1038/ng1951